European Depression in Diabetes (EDID) Research Consortium
The EDID Research Consortium comprises multidisciplinary groups of scientists who, under the auspices of the international PSAD Group, have joined forces to enhance understanding and knowledge of one of the most prevalent and costly mental health problems associated with diabetes, namely clinical depression.
The aims of the EDID Research Consortium are:
- To identify and implement research activities required to explore and resolve issues in the assessment, treatment and management of depression in diabetes, to help optimise clinical outcomes for people with diabetes
- To bring about consensus on important topics amongst leading psychologists, diabetologists, and others associated with the prevention, assessment, management and impact of depression among people with diabetes
- To provide a platform for an exchange of findings and theoretical approaches related to depression and diabetes
The European collaborative research framework provides an unique opportunity to examine how clinical issues related to the prevention, screening, assessment and treatment of depression differ across European countries/regions and health care settings. While common research questions will be examined in collaborative research projects, each participating group may also address specific independent research questions. To that effect, the EDID Research Consortium has agreed to:
- To include a common set of agreed measures in all EDID research, enabling comparison between studies
- To subject all relevant research activities to quality control procedures
- To make EDID research data available for a central EDID data bank, enabling group publications
EDID research groups are currently active in the UK, Netherlands, Germany, Slovenia, Croatia and Denmark.
The EDID Research Consortium’s network is supported by a grant from Novo Nordisk.
For more details on EDID, contact PSAD member and EDID Chair, Prof Arie Nouwen.